A REVIEW OF HEALTHCARE NEWS

Britain’s drug regulator accepted the Alzheimer’s drug Kisunla on Wednesday, but The federal government gained’t be paying for it immediately after an unbiased watchdog agency stated the treatment method isn’t well worth the Expense to taxpayersLocal climate transform, civil conflict and expanding resistance to insecticides and remedies are